In silico pharmaceutical property prediction

被引：0

作者：

Lee, Pil H. ^{[1
]}

Rafferty, Michael F. ^{[1
]}

机构：

[1] Pfizer Res & Dev, Ann Arbor, MI 48105 USA

来源：

MOLECULAR PHARMACEUTICS | 2007年 / 4卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：487 / 488

页数：2

共 50 条

[41] Theme Title: IN SILICO ADMET PREDICTIONS IN PHARMACEUTICAL RESEARCH
Hou, Tingjun
ADVANCED DRUG DELIVERY REVIEWS, 2015, 86 : 1 - 1
[42] Intellectual Property and the Pharmaceutical Industry: A Moral Crossroads Between Health and Property
Rivka Amado
Nevin M. Gewertz
Journal of Business Ethics, 2004, 55 : 295 - 308
[43] Intellectual property and the pharmaceutical industry: A moral crossroads between health and property
Gewertz, NM
Amado, R
JOURNAL OF BUSINESS ETHICS, 2004, 55 (03) : 295 - 308
[44] Probabilistic property prediction
Harlow, D. Gary
ENGINEERING FRACTURE MECHANICS, 2007, 74 (18) : 2943 - 2951
[45] CINF 68-Improving reliability of in silico ADME/Tox property prediction by incorporating in-house/proprietary data
Jurgutis, Paulius
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
[46] Intellectual property protection - Lifeline for the pharmaceutical industry
Cueni, TB
CHIMIA, 2000, 54 (05) : 318 - 320
[47] Intellectual property organizations and pharmaceutical patents in Africa
Deiss, Robert
SOCIAL SCIENCE & MEDICINE, 2007, 64 (02) : 287 - 291
[48] Intellectual property and pharmaceutical drugs: An ethical analysis
De George, RT
BUSINESS ETHICS QUARTERLY, 2005, 15 (04) : 549 - 575
[49] INTELLECTUAL PROPERTY PRACTICE IN THE PHARMACEUTICAL-INDUSTRY
BROWDER, MR
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 10 - CHAL
[50] COMPETITION LAW, INTELLECTUAL PROPERTY, AND THE PHARMACEUTICAL SECTOR
Kyle, Margaret K.
ANTITRUST LAW JOURNAL, 2016, 81 (01) : 1 - 36

← 1 2 3 4 5 →